The
global cilastatin sodium market size was accounted for USD 806 million in 2020 and expected to grow at a significant CAGR of 3.1% during the forecast period 2021 to 2027 and projected to reach over USD 990 million by 2027. The increasing incidence of lower respiratory tract infections is a primary factor to drive the market growth.
On the basis of clinical application, the segment is divided into lower respiratory tract infections, urinary tract infections, and other applications. The lower respiratory tract infection segment held the largest market share in 2020. As per a research study shared by WHO, 1.4 million people die each year due to tuberculosis across the globe.